Hudson Bay Capital Management LP
Institutional investor · Portfolio as of Q2 2020
Top Holdings489 positions
| 150.3M | $527.6M | 9.2% | — | — | 4 qtrssince 2019-Q3 | Increased 66 | |
| 127.9M | $384.1M | 6.7% | — | — | — | Increased 61 | |
| 55.9M | $367.1M | 6.4% | — | — | 7 qtrssince 2018-Q4 | Increased 75 | |
| 203.7M | $298.1M | 5.2% | — | — | 7 qtrssince 2018-Q4 | Increased 71 | |
| 102.3M | $228.7M | 4.0% | — | — | 7 qtrssince 2018-Q4 | Decreased 0 | |
GCI LIBERTY INC | 3M | $212.4M | 3.7% | — | — | — | Decreased 0 |
LEGEND BIOTECH CORP | 3.1M | $121.8M | 2.1% | $41.10 | 0.00% | 1 qtr | New 78 |
| 31.1M | $110.8M | 1.9% | — | — | 2 qtrssince 2020-Q1 | Unchanged 0 | |
Liberty Broadband Corp | 804,283 | $98.3M | 1.7% | $101.45 | +13.40% | 5 qtrssince 2019-Q2 | Decreased 0 |
VectoIQ Acquisition Corp | 2.1M | $96.2M | 1.7% | — | — | 1 qtr | New 68 |
DraftKings Inc | 2.7M | $91.3M | 1.6% | $33.54 | 0.00% | 1 qtr | New 68 |
| 73.6M | $78.8M | 1.4% | — | — | 5 qtrssince 2019-Q2 | Increased 58 | |
| 425,200 | $60.9M | 1.1% | — | — | 7 qtrssince 2018-Q4 | Increased 54 | |
| 156.7M | $55.4M | 1.0% | — | — | 6 qtrssince 2019-Q1 | Increased 48 | |
| 131.2M | $53.5M | 0.9% | — | — | 4 qtrssince 2019-Q3 | Increased 49 | |
| 51.8M | $52M | 0.9% | — | — | 2 qtrssince 2020-Q1 | Increased 67 | |
| 34.5M | $51.9M | 0.9% | — | — | 1 qtr | New 57 | |
| 19.5M | $48.5M | 0.8% | — | — | 1 qtr | New 57 | |
iShares iBoxx $ Investment Grade Corporate Bond ET | 350,000 | $47.1M | 0.8% | $106.84 | 0.00% | 1 qtr | New 57 |
| 24.3M | $45.4M | 0.8% | — | — | 6 qtrssince 2019-Q1 | Unchanged 0 |
Hudson Bay Capital Management LP manages $5.7B across 489 positions as of Q2 2020. Top holdings: TESLA INC (9.2%), SERVICENOW, INC. (6.7%), ADVANCED MICRO DEVICES INC (6.4%). Fund DNA: Diversified Scout. HoldingsIntel Score: 2/5.0.
Active quarter - 196 new positions, 197 exits, 126 increased. Top move: LEGN (NEW, conviction 78). Portfolio: $5.7B across 489 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR